Ximedica
Private Company
Total funding raised: $25M
Overview
Ximedica is a long-established, full-service contract design, development, and manufacturing organization (CDMO) for the medical technology sector. Unlike a biotech with its own pipeline, Ximedica operates a service-based business model, leveraging its integrated capabilities to de-risk and accelerate clients' product journeys. Its value proposition lies in offering a single-source solution from initial human factors research and industrial design through regulatory strategy, engineering, and scalable manufacturing. The company is positioned to capitalize on the growing trend of outsourcing in medtech and the complexity of combination products.
Technology Platform
Integrated service platform for medical device and combination product development, encompassing human factors research, industrial design, engineering (mechanical, electrical, software), regulatory strategy, quality systems, and commercial manufacturing.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Ximedica competes in a fragmented market against large, public CDMOs (e.g., Jabil, Flex), specialized engineering and design firms, and the in-house development teams of its own clients. Its differentiation lies in its integrated, end-to-end service offering from concept to commercial manufacturing.